Senomyx (SNMX) Stock Price, News & Analysis

Company Overview

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.

Key Stats

• Today's Range: $1.49 to $1.49
• 50-Day Range: N/A
• 52-Week Range: $0.83 to $1.71
• Volume: N/A
• Average Volume: 151,720 shs
• Market Capitalization: $72.03 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SNMX Stock Analysis - Frequently Asked Questions

How were Senomyx's earnings last quarter?

Senomyx, Inc. (NASDAQ:SNMX) posted its earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.01. The specialty chemicals company had revenue of $3.29 million for the quarter. Senomyx had a negative trailing twelve-month return on equity of 15.80% and a negative net margin of 9.11%.

What other stocks do shareholders of Senomyx own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC) and DURECT (DRRX).

Company Calendar

• Last Earnings: 8/02/2018
• Today: 7/10/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Commercial Physical Research
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SNMX
• CIK: 1123979
• Web: www.senomyx.com
• Phone: 858-646-8300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.26 million
• Net Margins: -9.11%
• Pretax Margin: N/A
• Return on Equity: -15.80%
• Return on Assets: -10.48%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.35
• Quick Ratio: 3.92

Sales & Book Value

• Annual Sales: $29.32 million
• Price / Sales: 2.46
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.39 per share
• Price / Book: 3.82

Miscellaneous

• Outstanding Shares: 48,340,000
• Free Float: N/A
• Market Cap: $72.03 million
• Optionable: Optionable
• Beta: 1.33